galaxystocks.com
Guggenheim Sees Upside In Aegerion (AEGR); AVEO Pharma (AVEO) Inks Mega-Deal
Brokerage firm Guggenheim has changed its view drastically on Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR) and upgraded the company’s stock from a Sell to a Buy rating with a price target of …